Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Other hematologic neoplasm 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Specimen Handling 3trastuzumab deruxtecan 1pembrolizumab 1pegamotecan 1fludarabine phosphate 1envafolimab 1cemiplimab 1apatinib 1aldesleukin 1X-Rays 1Vincristine 1Vaccines 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Nanoparticles 1Magnetic Resonance Spectroscopy 1Health Care Economics and Organizations 1HMPL-013 1Everolimus 1Cyclophosphamide 1Biopsy 1Biomarkers 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Antibodies, Monoclonal × Sarcoma × Clear all
NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

MedImmune LLC

Phase 1 Suspended
95 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡